Full metadata record

DC Field Value Language
dc.contributor.authorEl-Din, Mahmoud M. Gamal-
dc.contributor.authorEl-Gamal, Mohammed I.-
dc.contributor.authorAbdel-Maksoud, Mohammed S.-
dc.contributor.authorYoo, Kyung Ho-
dc.contributor.authorOh, Chang-Hyun-
dc.date.accessioned2024-01-20T08:01:04Z-
dc.date.available2024-01-20T08:01:04Z-
dc.date.created2022-01-10-
dc.date.issued2015-01-27-
dc.identifier.issn0223-5234-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/125848-
dc.description.abstractSynthesis of a new series of 1,3,4-oxadiazole derivatives possessing sulfonamide moiety is described. Their in vitro antiproliferative activities against NCI-58 human cancer cell lines of nine different cancer types were tested. Compound 1k with p-methoxybenzenesulfonamido moiety showed the highest mean %inhibition value over the 58 cell line panel at 10 mu M concentration. It showed broad-spectrum antiproliferative activity over many cell lines of different cancer types. For instance, compound 1k inhibited the growth of T-47D breast cancer cell line by 90.47% at 10 mu M. And it inhibited growth of SR leukemia, SK-MEL-5 melanoma, and MDA-MB-468 breast cancer cell lines by more than 80% at the same test concentration. Compound 1k showed superior activity than Paditaxel and Gefitinib against the most sensitive cell lines. (C) 2014 Elsevier Masson SAS. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER-
dc.subjectBIOLOGICAL EVALUATION-
dc.subjectANTICANCER ACTIVITY-
dc.subjectBEARING OXADIAZOLE-
dc.subjectDESIGN-
dc.subjectAGENTS-
dc.subjectINHIBITORS-
dc.subjectCANCER-
dc.subjectNUCLEUS-
dc.subjectSERIES-
dc.subjectACID-
dc.titleSynthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety-
dc.typeArticle-
dc.identifier.doi10.1016/j.ejmech.2014.11.011-
dc.description.journalClass1-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.90, pp.45 - 52-
dc.citation.titleEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY-
dc.citation.volume90-
dc.citation.startPage45-
dc.citation.endPage52-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000348951900005-
dc.identifier.scopusid2-s2.0-84910110586-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusBIOLOGICAL EVALUATION-
dc.subject.keywordPlusANTICANCER ACTIVITY-
dc.subject.keywordPlusBEARING OXADIAZOLE-
dc.subject.keywordPlusDESIGN-
dc.subject.keywordPlusAGENTS-
dc.subject.keywordPlusINHIBITORS-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusNUCLEUS-
dc.subject.keywordPlusSERIES-
dc.subject.keywordPlusACID-
dc.subject.keywordAuthorAntiproliferative activity-
dc.subject.keywordAuthor1,3,4-Oxadiazole-
dc.subject.keywordAuthorSulfonamide-
Appears in Collections:
KIST Article > 2015
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE